Jose María Mateo Aguado-rekin lankidetzan egindako argitalpenak (29)

2014

  1. Enterococcal infection in kidney transplant recipients in a setting of low prevalence of vancomycin resistance

    Transplant Infectious Disease

  2. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation

    Transplant International, Vol. 27, Núm. 7, pp. 674-685

2013

  1. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  2. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693

  3. Hypocomplementemia in kidney transplant recipients: Impact on the risk of infectious complications

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 685-694

  4. Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors

    Transplantation Proceedings

  5. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients

    Transplant Infectious Disease, Vol. 15, Núm. 6, pp. 600-611

2012

  1. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection

    American Journal of Transplantation, Vol. 12, Núm. 10, pp. 2763-2773

2011

  1. Acute graft pyelonephritis in renal transplant recipients: Incidence, risk factors and long-term outcome

    Nephrology Dialysis Transplantation, Vol. 26, Núm. 3, pp. 1065-1073

2010

  1. Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients

    Kidney International, Vol. 78, Núm. 8, pp. 774-781

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

  2. Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients

    Transplant Infectious Disease, Vol. 11, Núm. 5, pp. 400-404

2008

  1. Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: Experience with kidney transplantation

    Transplant International, Vol. 21, Núm. 9, pp. 873-878

  2. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: An underdiagnosed etiology for obstructive uropathy and graft dysfunction - Results of a prospective cohort study

    Clinical Infectious Diseases, Vol. 46, Núm. 6, pp. 825-830

2006

  1. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients

    Transplantation, Vol. 82, Núm. 1, pp. 30-35

2005

  1. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients

    Transplantation Proceedings

  2. Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients

    Transplantation Proceedings

  3. Is double renal transplantation a risk factor for cytomegalovirus disease?

    Transplantation Proceedings

2002

  1. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 97

  2. Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 73-74